Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Fallopian Tube CancerOvarian Cancer
Interventions
DRUG

carboplatin

DRUG

paclitaxel

DRUG

topotecan hydrochloride

Trial Locations (19)

30659

Frauenklinik der MHH, Hanover

39108

Klinik der Otto-v.-Guericke-Universitat, Magdeburg

D-10117

Universitaetsklinikum Charite, Berlin

D-53105

Universitaetskliniken Bonn, Bonn

D-28205

Zentralkrankenhaus, Bremen

D-01307

Medizinische Klinik I, Dresden

D-40225

Universitaetsklinik Duesseldorf, Düsseldorf

DOH-4-0217

Evangelisches Krankenhaus, Düsseldorf

D-60590

Klinikum der J.W. Goethe Universitaet, Frankfurt

DOH-6-5929

Stadtische Kliniken Frankfurt-Hochst, Frankfurt

D-37075

Universitaetsklinik Goettingen, Göttingen

D-17487

Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald

D-76137

Vincentius Krankenhaus, Karlsruhe

D-24105

Christian-Albrechts University of Kiel, Kiel

D-81377

Klinikum Grosshadern, Munich

D-81675

Klinikum Rechts Der Isar/Technische Universitaet Muenchen, Munich

D-48129

Klinik und Poliklinik fuer Kinderheilkunde, Münster

D-72076

Universitaetsklinikum Tuebingen, Tübingen

D-65199

Dr. Horst-Schmidt-Kliniken, Wiesbaden

All Listed Sponsors
lead

AGO Study Group

OTHER

NCT00006454 - Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter